Skip to main content
. 2020 Jan 21;15(1):e0228072. doi: 10.1371/journal.pone.0228072

Table 1. Study design for HDR-treated dogs.

Dogs were assessed 3 months after treatment.

Treatment Dog Age of injection Sex
1 sgRNA A Friendly 8yr M
2 sgRNA A Miercoles 5yr F
3 sgRNA B Bubbles 1.5yr F
4 sgRNA B Clove 4mos F
5 TALEN Hera 3mos F
6 TALEN Gantu 7mos M